Skip to main content

Market Access Monitor

Service of monitoring key reimbursement and HTA developments for medical devices, in-vitro diagnostic tests, and digital technologies in Europe and globally

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Application window for the assessment of procedures and IVD tests opened in France

In April 2025, the French National Authority for Health (HAS) launched its annual call for applications to evaluate medical procedures and in-vitro diagnostic tests. Selected submissions will be included in the HAS 2026 working program. 

Inclusion in the HAS working program provides for the formal evaluation by the HAS, which is required to establish eligibility for reimbursement.

Applications may request the creation of a novel reimbursement code, removal of existing codes, or modification of registration conditions for services listed in the following nomenclatures: the Common Classification of Medical Procedures (CCAM), the General Nomenclature of Professional Procedures (NGAP), and the Nomenclature of Medical Biology Procedures (NABM).

Eligible applicants, including National Professional Councils (CNP) and manufacturers, must submit applications via the online EVActe platform by July 8, 2025.

See the details in French here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.